
U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices and Others) Forecast up to 2027

U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices and Others) Forecast up to 2027
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices and Others) Forecast up to 2027
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Expanded Carrier Screening
5.2.1. Customized Panel Testing
5.2.2. Predesigned Panel Testing
5.3. Targeted Disease Carrier Screening
6. Technology: Market Size & Analysis
6.1. Overview
6.2. DNA Sequencing
6.3. Polymerase Chain Reaction
6.4. Microarrays
6.5. Others
7. End User: Market Size & Analysis
7.1. Overview
7.2. Hospitals & Clinics
7.3. Reference Laboratories
7.4. Physician Offices
7.5. Others
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. Myriad Genetics Inc.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Thermo Fisher Scientific Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. PerkinElmer Inc.
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Fulgent Genetics Inc.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Quest Diagnostics Incorporated
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Invitae Corporation
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Illumina Inc.
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Natera Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. LabCorp
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Sema4
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
Tables & Figures:
TABLE 1. GLOBAL U.S. CARRIER SCREENING MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR EXPANDED CARRIER SCREENING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR TARGETED DISEASE CARRIER SCREENING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL U.S. CARRIER SCREENING MARKET VALUE, BY TECHNOLOGY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR DNA SEQUENCING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR MICROARRAYS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL U.S. CARRIER SCREENING MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR REFERENCE LABORATORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR PHYSICIAN OFFICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. U.S. CARRIER SCREENING MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 15. U.S. CARRIER SCREENING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)
TABLE 16. U.S. CARRIER SCREENING MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 17. MYRIAD GENETICS INC.: FINANCIALS
TABLE 18. MYRIAD GENETICS INC.: PRODUCTS & SERVICES
TABLE 19. MYRIAD GENETICS INC.: RECENT DEVELOPMENTS
TABLE 20. THERMO FISHER SCIENTIFIC INC.: FINANCIALS
TABLE 21. THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES
TABLE 22. THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS
TABLE 23. PERKINELMER INC.: FINANCIALS
TABLE 24. PERKINELMER INC.: PRODUCTS & SERVICES
TABLE 25. PERKINELMER INC.: RECENT DEVELOPMENTS
TABLE 26. FULGENT GENETICS INC.: FINANCIALS
TABLE 27. FULGENT GENETICS INC.: PRODUCTS & SERVICES
TABLE 28. FULGENT GENETICS INC.: RECENT DEVELOPMENTS
TABLE 29. QUEST DIAGNOSTICS INCORPORATED: FINANCIALS
TABLE 30. QUEST DIAGNOSTICS INCORPORATED: PRODUCTS & SERVICES
TABLE 31. QUEST DIAGNOSTICS INCORPORATED: RECENT DEVELOPMENTS
TABLE 32. INVITAE CORPORATION: FINANCIALS
TABLE 33. INVITAE CORPORATION: PRODUCTS & SERVICES
TABLE 34. INVITAE CORPORATION: RECENT DEVELOPMENTS
TABLE 35. ILLUMINA INC.: FINANCIALS
TABLE 36. ILLUMINA INC.: PRODUCTS & SERVICES
TABLE 37. ILLUMINA INC.: RECENT DEVELOPMENTS
TABLE 38. NATERA INC.: FINANCIALS
TABLE 39. NATERA INC.: PRODUCTS & SERVICES
TABLE 40. NATERA INC.: RECENT DEVELOPMENTS
TABLE 41. LABCORP: FINANCIALS
TABLE 42. LABCORP: PRODUCTS & SERVICES
TABLE 43. LABCORP: RECENT DEVELOPMENTS
TABLE 44. SEMA4: FINANCIALS
TABLE 45. SEMA4: PRODUCTS & SERVICES
TABLE 46. SEMA4: RECENT DEVELOPMENTS
Research Methodology:
U.S. Carrier Screening Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|